What should be included in a private-label vapor hardware packaging RFQ?

A packaging RFQ should describe the project, not just attach a logo. The buyer needs to identify what product is being considered, where it is intended to be sold, what packaging questions need review, and which commercial or documentation decisions remain open. This keeps a creative brief, a technical package brief, and a regulatory-status question from being treated as the same approval.

RFQ inputWhat the buyer should provideWhat still requires confirmation
Product identityHardware platform, configuration, component questions, and commercial route.Product-specific availability, final specification, and permitted program scope.
Brand & artworkApproved business contact, brand files, required languages, intended claims, and package-copy questions.Artwork acceptance, product-specific warnings, and market-specific label requirements.
Package structureRequested format, inserts, labels, quantity range, and handling or shipping considerations.Final dielines, dimensions, materials, pack-out, and quality requirements for the exact project.
Market & documentationDestination, anticipated timeline, importer context, and requested technical, quality, or status documents.Product-specific regulatory status, required documents, and destination-dependent requirements.

Why should product identity come before packaging artwork?

Packaging is connected to a defined product and a defined market. A category image, standard box concept, or prior project does not identify the exact hardware configuration, component set, labeling route, or documentation that will apply to a new private-label discussion. Start with the product reference gallery, then use the OEM / ODM / private-label process to establish the correct project route before asking for a package decision.

How should warnings and label content be handled for U.S. projects?

Route package copy for product- and market-specific review; do not copy a general statement into final artwork. FDA identifies labeling and warning statement requirements for tobacco products and directs readers to covered-product materials that include vaporizers, e-cigarettes, and other electronic nicotine delivery systems.[^1] The applicable content and presentation should be confirmed for the exact product and transaction through the proper review process.

Artwork should remain adult-oriented and factual. Do not submit health, cessation, reduced-risk, youth-oriented, or unverified certification or authorization claims. A packaging review does not convert a marketing statement into an approved claim.

When do liquid nicotine container packaging questions require separate review?

CPSC guidance states that the Child Nicotine Poisoning Prevention Act requires liquid nicotine containers that are sold, offered for sale, manufactured for sale, distributed in commerce, or imported into the United States to use packaging that meets the cited special-packaging requirements.[^2] This is a conditional question: identify whether the proposed project includes a liquid nicotine container rather than assume that the same point applies to every hardware-only package.

What is the right private-label packaging approval sequence?

Use a staged review that keeps commercial, technical, artwork, and regulatory-status decisions separate.

  1. Define the product and market. Identify the platform, intended destination, project route, and documentation questions.
  2. Submit a controlled brand brief. Provide approved assets, intended copy, language needs, and package-format questions through the B2B process.
  3. Review open requirements. Record which questions concern commercial scope, product configuration, artwork, warnings, logistics, or documentation.
  4. Approve only through the applicable project process. Treat final files, schedule, MOQ, product status, and shipment eligibility as transaction-specific confirmations, not website defaults.

Why does packaging not confirm a product’s U.S. marketing status?

Packaging and product status are separate questions. FDA states that a company must receive a written marketing order to legally market a new tobacco product in the United States.[^3] A logo placement, dieline, or artwork discussion does not answer whether a specific product may be legally marketed. Request product-specific status information through the verified-buyer route and seek qualified legal or regulatory advice when appropriate.

What should a buyer avoid before packaging is approved?

Do not assume that an initial mockup, generic warning, standard package, or previous configuration is approved for the proposed model, intended market, or transaction. Do not use consumer-facing health, cessation, reduced-risk, youth-oriented, or unverified regulatory claims. Do not treat a B2B website reference as a complete specification, label approval, or shipping authorization.

Frequently asked questions

What should a private-label vapor hardware packaging RFQ include?

A packaging RFQ should identify the exact hardware configuration, intended market, approved brand assets, package format or structural questions, required artwork deliverables, product-specific documentation requests, anticipated quantity range, timing, and the authorized business contact. It should distinguish open items from approved specifications.

Can a packaging design or artwork review confirm U.S. regulatory status?

No. Packaging or artwork review cannot confirm that a product has U.S. marketing authorization, is commercially available, or meets all requirements for a particular transaction. Confirm product-specific status through the verified-buyer process and qualified review.

When do liquid nicotine packaging requirements matter?

CPSC guidance addresses liquid nicotine containers. If a proposed project includes nicotine provided in a liquid nicotine container for the U.S. market, packaging questions should be routed for product-specific review. Do not infer that this requirement applies to every hardware-only package or configuration.

What should a buyer avoid before packaging artwork is approved?

A buyer should avoid assuming that a general design, generic warning, previous project, or packaging mockup is approved for the intended product or market. The buyer should not use unsupported health, reduced-risk, cessation, youth-oriented, or unverified regulatory claims in submitted artwork.

Qualified next step

Use the Request a Quote form to share the hardware platform, intended market, package-format questions, approved brand assets, documentation needs, anticipated quantity range, and timing. This route is for licensed adult B2B buyers only.

Sources and further reading

[^1]: U.S. Food and Drug Administration, “Labeling and Warning Statements for Tobacco Products”, accessed September 23, 2026. [^2]: U.S. Consumer Product Safety Commission, “Liquid Nicotine Packaging Business Guidance”, accessed September 23, 2026. [^3]: U.S. Food and Drug Administration, “Tobacco Products Marketing Orders”, accessed September 23, 2026.

Published by Autosweave Labs B2B Editorial Team. Last updated September 23, 2026.